Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$435K Sell
10,207
-69
-0.7% -$3.08K 0.27% 103
2026
Q1
$495K Buy
10,276
+68
+0.7% +$3.17K 0.35% 82
2025
Q4
$495K Hold
10,208
– – 0.37% 83
2025
Q3
$482K Hold
10,208
– – 0.37% 87
2025
Q2
$493K Buy
+10,208
New +$522K 0.41% 76

Other funds holding SNY

Rexford Capital's SNY Position: Q2 2026 in Review

Rexford Capital reduced its Sanofi (SNY) stake by 0.67% in Q2 2026, selling an estimated $3.08K and leaving 10,207 shares worth $435K. The position accounts for 0.27% of the portfolio, ranked #103.

Rexford Capital first reported a position in SNY in Q2 2025 and has held it in 5 quarters since. The position peaked at $495K in Q1 2026. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Rexford Capital held 10,207 shares of Sanofi worth $435K as of Q2 2026.
  • Rexford Capital sold 69 Sanofi shares in Q2 2026, an estimated $3.08K.
  • Sanofi made up 0.27% of Rexford Capital's portfolio in Q2 2026, its #103 holding.
  • Rexford Capital first reported a position in Sanofi in Q2 2025 and has held it in 5 quarters since.
  • Rexford Capital's Sanofi position peaked at $495K in Q1 2026.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Rexford Capital's 13F filing for Q2 2026, filed 29 Jul 2026.